Saturday 17 October 2026
Export MBOT’s income statement to Excel — free account
Microbot Medical Inc.
MBOT Healthcare Medical Instruments & Supplies
In the quarter to June 2026, revenue grew 1,047.6%, EPS grew 20.0% and free cash flow fell 98.7%, each against the same quarter a year earlier.
0.95
0.00
0.00%
Follow MBOT
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
4.23 | 20.70 | 1.23 | 7.45 | 18.78 | 8.00 | 4.26 | 2.09 | 2.37 | 23.33 |
Net Debt/EBITDA |
0.27 | 2.06 | 0.73 | 4.98 | 2.74 | 1.38 | 0.63 | 0.66 | 0.48 | 5.35 |
Debt/Assets |
2.26% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.14 | 0.81 | 0.73 | 0.89 | 0.79 | 0.83 | 0.88 | 0.79 | 0.77 | 0.99 |
Capex/Depreciation |
(2.50) | (2.76) | (4.13) | 0.51 | (1.34) | (0.91) | (0.82) | (0.31) | (0.27) | (1.28) |
| (558.34%) | (94.90%) | (123.11%) | (44.09%) | (32.84%) | (58.48%) | (121.53%) | (182.19%) | (284.97%) | (32.42%) | |
| (292.99%) | (83.50%) | (84.86%) | (33.54%) | (28.92%) | (52.56%) | (100.12%) | (120.24%) | (159.40%) | (30.01%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(220.85%) | (57.25%) | (545.86%) | (23.13%) | (37.95%) | (80.01%) | (189.03%) | (250.88%) | (332.74%) | (17.18%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.85) | (2.26) | (1.91) | (1.50) | (1.03) | (1.33) | (1.60) | (0.84) | (0.57) | (0.29) |
Cash per Share |
2.84 | 4.96 | 1.81 | 8.35 | 3.47 | 2.19 | 1.14 | 0.63 | 0.35 | 1.72 |
Shareholders Equity per Share |
2.30 | 4.80 | 0.46 | 7.39 | 3.42 | 2.02 | 1.00 | 0.44 | 0.23 | 1.69 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.30 | 4.80 | 0.46 | 7.39 | 3.42 | 2.02 | 1.00 | 0.44 | 0.23 | 1.69 |
Free Cash Flow |
(0.81) | (4.91) | (5.53) | (6.41) | (7.34) | (9.42) | (11.63) | (8.57) | (8.85) | (13.11) |
Working Capital |
2.53 | 10.40 | 1.07 | 31.11 | 23.91 | 13.90 | 6.75 | 4.14 | 3.36 | 76.40 |
Capital Expenditures |
(0.02) | (0.06) | (0.22) | 0.04 | (0.09) | (0.07) | (0.08) | (0.03) | (0.02) | (0.06) |
Net Current Asset Value |
2.14 | 10.37 | 1.07 | 30.35 | 23.28 | 13.49 | 6.57 | 4.10 | 3.32 | 75.83 |
| Other line items | ||||||||||
Quick Ratio |
3.48 | 20.55 | 1.12 | 7.41 | 18.64 | 7.94 | 4.05 | 2.05 | 2.24 | 22.97 |
Depreciation/Fixed assets |
0.19 | 0.23 | 0.21 | 0.37 | 0.27 | 0.31 | 0.46 | 0.73 | 1.14 | 0.51 |
Cash ROIC |
(16.28%) | (23.09%) | (83.92%) | (9.54%) | (14.97%) | (31.45%) | (74.71%) | (78.34%) | (97.82%) | (8.39%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.82) | (2.23) | (1.83) | (1.51) | (1.02) | (1.32) | (1.59) | (0.84) | (0.56) | (0.28) |
Capex per Share |
(0.03) | (0.03) | (0.08) | 0.01 | (0.01) | (0.01) | (0.01) | 0.00 | 0.00 | 0.00 |
Average Receivables |
0.03 | 0.03 | 0.05 | 0.08 | 0.22 | 0.26 | 0.14 | 0.72 | — | — |
Average Payables |
0.27 | 0.30 | 0.35 | 0.46 | 0.28 | 0.28 | 0.20 | 0.24 | 0.26 | 0.34 |
Average Assets |
1.95 | 7.19 | 8.56 | 21.61 | 31.70 | 21.52 | 13.15 | 8.93 | 7.18 | 43.79 |
Average Common Equity |
1.02 | 6.33 | 5.90 | 16.44 | 27.92 | 19.34 | 10.84 | 5.90 | 4.02 | 40.54 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates